Mediso Medical Imaging Systems Ltd.

Mediso works in the field of Nuclear Medicine and molecular imaging for 35 years with a profile of development, manufacturing, selling and servicing standalone and multi-modality imaging devices.

With more than 1400 clinical and 350 preclinical systems in over 100 countries worldwide, Mediso is the only company offering molecular imaging systems for both clinical patient care and scientific research.

Its clinical portfolio ranges from Gamma Cameras developed for routine examinations, through SPECT and SPECT/CT systems intended for general diagnostic use, to complex hybrid equipment uniquely integrating three modalities. The latest AnyScan® TRIO-TheraMAX SPECT/CT features extreme sensitivity with uncompromised PET-like image quality ensuring ultra-fast, quantitative, total-body scans in theranostic applications even at high energies.